Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulf Müller

Showing results (231-240 of 301) with videos related to

Pageof 31
Sort By:
Arthritis Research & Therapy|December 11, 2014
Borderline pulmonary arterial pressure in systemic sclerosis patients: a post-hoc analysis of the DETECT studyScott H Visovatti, Oliver Distler, J Gerry Coghlan, et al.
Zeitschrift Fur Rheumatologie|March 19, 2026
[Proposal of the rheumatology societies in the D-A-CH region for a uniform German nomenclature for Sjögren's disease]Diana Ernst, , Thomas Dörner, et al.
Science Translational Medicine|April 26, 2019
A CD40L-targeting protein reduces autoantibodies and improves disease activity in patients with autoimmunityJodi L Karnell, Marius Albulescu, Stacey Drabic, et al.
Autoimmunity Reviews|September 15, 2019
Fast track algorithm: How to differentiate a "scleroderma pattern" from a "non-scleroderma pattern"Vanessa Smith, Amber Vanhaecke, Ariane L Herrick, et al.
BMC Rheumatology|July 31, 2021
The Joint Vasculitis Registry in German-speaking countries (GeVas) - a prospective, multicenter registry for the follow-up of long-term outcomes in vasculitisChristof Iking-Konert, Pia Wallmeier, Sabrina Arnold, et al.
Clinical and Experimental Rheumatology|May 17, 2022
Health-related quality of life in patients with mixed connective tissue disease: a comparison with matched systemic sclerosis patientsImane Abouyahya, Sophie I E Liem, Zahir Amoura, et al.
The Journal of Rheumatology|September 18, 2012
Efficacy and safety of rituximab treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitides: results from a German registry (GRAID)Petra Roll, Eva Ostermeier, Marion Haubitz, et al.
Rheumatology (Oxford, England)|December 7, 2013
Nailfold capillary abnormalities in erectile dysfunction of systemic sclerosis: a EUSTAR group analysisAndrea D Keck, Chingching Foocharoen, Edoardo Rosato, et al.
Thorax|October 5, 2023
Phenotyping by persistent inflammation in systemic sclerosis associated interstitial lung disease: a EUSTAR database analysisSabina Guler, Adela-Cristina Sarbu, Odile Stalder, et al.
Rheumatology (Oxford, England)|October 28, 2017
Patient acceptable symptom state in scleroderma: results from the tocilizumab compared with placebo trial in active diffuse cutaneous systemic sclerosisMichael B Arnold, Dinesh Khanna, Christopher P Denton, et al.
Pageof 31

Showing results (231-240 of 301) with videos related to

Sort By:
Pageof 31
Arthritis Research & Therapy|December 11, 2014
Borderline pulmonary arterial pressure in systemic sclerosis patients: a post-hoc analysis of the DETECT studyScott H Visovatti, Oliver Distler, J Gerry Coghlan, et al.
Zeitschrift Fur Rheumatologie|March 19, 2026
[Proposal of the rheumatology societies in the D-A-CH region for a uniform German nomenclature for Sjögren's disease]Diana Ernst, , Thomas Dörner, et al.
Science Translational Medicine|April 26, 2019
A CD40L-targeting protein reduces autoantibodies and improves disease activity in patients with autoimmunityJodi L Karnell, Marius Albulescu, Stacey Drabic, et al.
Autoimmunity Reviews|September 15, 2019
Fast track algorithm: How to differentiate a "scleroderma pattern" from a "non-scleroderma pattern"Vanessa Smith, Amber Vanhaecke, Ariane L Herrick, et al.
BMC Rheumatology|July 31, 2021
The Joint Vasculitis Registry in German-speaking countries (GeVas) - a prospective, multicenter registry for the follow-up of long-term outcomes in vasculitisChristof Iking-Konert, Pia Wallmeier, Sabrina Arnold, et al.
Clinical and Experimental Rheumatology|May 17, 2022
Health-related quality of life in patients with mixed connective tissue disease: a comparison with matched systemic sclerosis patientsImane Abouyahya, Sophie I E Liem, Zahir Amoura, et al.
The Journal of Rheumatology|September 18, 2012
Efficacy and safety of rituximab treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitides: results from a German registry (GRAID)Petra Roll, Eva Ostermeier, Marion Haubitz, et al.
Rheumatology (Oxford, England)|December 7, 2013
Nailfold capillary abnormalities in erectile dysfunction of systemic sclerosis: a EUSTAR group analysisAndrea D Keck, Chingching Foocharoen, Edoardo Rosato, et al.
Thorax|October 5, 2023
Phenotyping by persistent inflammation in systemic sclerosis associated interstitial lung disease: a EUSTAR database analysisSabina Guler, Adela-Cristina Sarbu, Odile Stalder, et al.
Rheumatology (Oxford, England)|October 28, 2017
Patient acceptable symptom state in scleroderma: results from the tocilizumab compared with placebo trial in active diffuse cutaneous systemic sclerosisMichael B Arnold, Dinesh Khanna, Christopher P Denton, et al.
Pageof 31